By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Pravastatin

Pravastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
6 Min Read
SHARE
4 min read|790 words

What is Pravastatin?

Pravastatin is a prescription medication that belongs to a class of drugs called statins or HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels and reduce the risk of heart disease and stroke in people with elevated cholesterol or other cardiovascular risk factors. Pravastatin works by blocking an enzyme in the liver that produces cholesterol, helping to decrease both total cholesterol and low-density lipoprotein (LDL or “bad”) cholesterol levels.

Uses

High cholesterol (hypercholesterolemia): Pravastatin is commonly prescribed to reduce elevated LDL cholesterol and total cholesterol levels when diet and lifestyle changes alone are insufficient.

Primary prevention of cardiovascular disease: The medication is used in people without existing heart disease but who have risk factors such as diabetes, high blood pressure, or family history of heart disease.

Secondary prevention after heart attack or stroke: Pravastatin helps prevent future cardiovascular events in patients who have already experienced a heart attack, stroke, or other cardiovascular complications.

Submit Your Paper
GMJ_Submit_Banner

Mixed dyslipidemia: It can be prescribed to improve overall lipid profiles in patients with multiple cholesterol abnormalities, including elevated triglycerides and low HDL (“good”) cholesterol.

Familial hypercholesterolemia: Pravastatin may be used as part of treatment for inherited conditions that cause extremely high cholesterol levels from childhood.

How it works

Pravastatin works by inhibiting HMG-CoA reductase, a key enzyme involved in cholesterol production in the liver. By blocking this enzyme, the medication reduces the liver’s ability to manufacture cholesterol, which forces the liver to remove more cholesterol from the bloodstream to meet its needs. This process leads to lower levels of total cholesterol and LDL cholesterol in the blood, while often providing modest increases in beneficial HDL cholesterol.

Side effects

Common side effects:

  • Muscle aches and pain (myalgia)
  • Headache
  • Nausea and stomach upset
  • Diarrhea or constipation
  • Dizziness
  • Fatigue
  • Skin rash
  • Sleep disturbances

Serious side effects requiring immediate medical attention:

  • Severe muscle pain, weakness, or breakdown (rhabdomyolysis)
  • Signs of liver problems including yellowing of skin or eyes, dark urine, or persistent abdominal pain
  • Unexplained muscle tenderness with fever or general feeling of illness
  • Memory problems or confusion
  • New onset diabetes or worsening blood sugar control

Warnings and precautions

Patients with active liver disease or unexplained persistent elevations in liver enzymes should not take pravastatin, and regular liver function monitoring may be recommended during treatment. The medication should be used with caution in people who consume large amounts of alcohol or have a history of liver disease. Pravastatin is generally considered safe during pregnancy (Pregnancy Category X has been updated – consult current prescribing information), but women who are pregnant, planning to become pregnant, or breastfeeding should discuss risks and benefits with their healthcare provider. Patients with kidney impairment may require dose adjustments, and those with a history of muscle problems or taking certain other medications may need closer monitoring for muscle-related side effects. Elderly patients may be more susceptible to side effects and may require lower starting doses.

Interactions

Warfarin and other blood thinners: Pravastatin may enhance the effects of anticoagulant medications, requiring more frequent monitoring of blood clotting times.

Cyclosporine: This immunosuppressive drug can significantly increase pravastatin levels in the blood, raising the risk of muscle damage.

Gemfibrozil and other fibrates: Combining these cholesterol medications with pravastatin increases the risk of serious muscle problems and should generally be avoided.

Niacin (high-dose): Large doses of niacin combined with pravastatin may increase the risk of muscle toxicity, particularly in patients with kidney problems.

Certain antibiotics: Some antibiotics like clarithromycin and erythromycin may increase pravastatin levels and associated side effects.

Antifungal medications: Drugs like itraconazole and ketoconazole can increase pravastatin concentrations in the bloodstream.

HIV protease inhibitors: These medications may significantly increase pravastatin levels, potentially requiring dose adjustments.

Grapefruit juice: While the interaction is generally less significant with pravastatin compared to other statins, large amounts may still affect drug levels.

Check interactions with the GMJ Interaction Checker

Dosage

For adults, pravastatin is typically started at 40 mg once daily, usually taken in the evening. The dosage range generally falls between 10 mg to 80 mg daily, depending on the patient’s cholesterol levels, cardiovascular risk factors, and response to treatment. Some patients may start with lower doses (10-20 mg) if they are elderly, have kidney problems, or are at higher risk for side effects. The maximum recommended dose is 80 mg daily, though most patients achieve their cholesterol goals with lower doses. Dosage adjustments should always be made under the guidance of a healthcare provider, who will monitor cholesterol levels and assess the need for dose changes every 6-8 weeks until target levels are achieved.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Pravastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/pravastatin-6/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Atorvastatin

By
GMJ News Desk
01/06/2026

Pravastatin

By
GMJ News Desk
01/06/2026

Rosuvastatin

By
GMJ News Desk
01/06/2026

Pravastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up